Allen, Elizabeth
Oncurious NV, Leuven, Belgium
3 papers on CoChatORCID 0000-0002-5379-2668
Most cited papers
- Verified
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Allen, E., Jabouille, A., Rivera, L. B., Lodewijckx, I., Missiaen, R., Steri, V., Feyen, K., Tawney, J., Hanahan, D., Michael, I. P., et al. (2017) · Science Translational Medicine
Cancer Immunotherapy and BiomarkersAngiogenesis and VEGF in Cancer
Cited by 820
- Verified
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
Allen, E., Miéville, P., Warren, C. M., Saghafinia, S., Li, L., Peng, M.-W., & Hanahan, D. (2016) · Cell Reports
Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer
Cited by 221
- Verified
Therapeutic depletion of CCR8 + tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
Van Damme, H., Dombrecht, B., Kiss, M., Roose, H., Allen, E., Van Overmeire, E., Kancheva, D., Martens, L., Murgaski, A., Bardet, P. M. R., et al. (2021) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 205
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free